Searching for Comprehensive Genomic Information? Get results faster using Guardant360®

What is Comprehensive Genomic Profiling? - How It Helps Cancer TreatmentПодробнее

FDA approved, Guardant360 CDx delivers critical genomic info to oncologists from simple blood draw.Подробнее

85.7 percent had objective tumor response after Guardant360® testПодробнее

Using Guardant360® For Advanced Stage Cancer Patients During COVID-19 PandemicПодробнее

Comprehensive genomic profiling for cancerПодробнее

Guardant360® test results show more than 90% agreement with tissue (Findings from NILE Study)Подробнее

Guardant360’s Comprehensive Genotyping in NSCLCПодробнее

Guardant360 CDx Liquid BiopsyПодробнее

Guardant360® detects more guideline-recommended biomarkers than tissue testingПодробнее

Weighing up evidence in genomic testingПодробнее

What is Guardant360 TissueNext™ & How Can It Inform Cancer Treatment?Подробнее

Comprehensive Genomic Characterization of Cutaneous Melanoma - Ian WatsonПодробнее

Guardant360® CDx receives FDA ApprovalПодробнее

What is Guardant360® CDx?Подробнее

Bioinformatics: Gaining insights from genomic dataПодробнее

Cancer genomic testing for patients with a simple blood drawПодробнее

Capturing genomic dataПодробнее

Colorectal Cancer Patient Case - where the Guardant360® test was usedПодробнее

What is Comprehensive Genomic Profiling for Cancer?Подробнее